Sub Category
Study Name
A Phase 2 Randomized, Controlled Study with a Phase 1 Safety Cohort testing ALD0401 Derived from Autologous Bone Marrow Delivered via Intracarotid Infusion in Subjects with Ischemic Stroke using Blinded Assessments Protocol IS-001 (IND 14484)
Principal Investigator
Syed Hussain, MD
Study Information
Must be having a stroke
Contact for Questions
Erin Shell 937-608-0386

Site view: at a glance